Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.120
+0.030 (2.75%)
At close: Jul 21, 2025, 4:00 PM
1.130
+0.010 (0.89%)
After-hours: Jul 21, 2025, 7:59 PM EDT
Canopy Growth Revenue
In the fiscal year ending March 31, 2025, Canopy Growth had annual revenue of 269.00M CAD, down -9.47%. Canopy Growth had revenue of 65.03M in the quarter ending March 31, 2025, a decrease of -10.66%.
Revenue (ttm)
269.00M CAD
Revenue Growth
-9.47%
P/S Ratio
1.13
Revenue / Employee
280,203 CAD
Employees
960
Market Cap
211.07M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CGC News
- 2 days ago - Top Canadian Cannabis Picks for U.S. Market Expansion in 2025 - MarijuanaStocks
- 7 days ago - 3 Top Canadian Marijuana Stocks To Watch As The Sector Looks To Bounce - MarijuanaStocks
- 10 days ago - 3 Marijuana Stocks To Watch: Key Trends Driving Cannabis Industry Growth - MarijuanaStocks
- 11 days ago - Canopy Growth Launches Deep Space Infused Pre-Rolls - Business Wire
- 12 days ago - Canopy Growth Appoints Tom Stewart as Interim Chief Financial Officer - Business Wire
- 13 days ago - Storz & Bickel Named “Equipment Provider of the Year” at Business of Cannabis Awards 2025 - Business Wire
- 16 days ago - Americans Should Buy Canadian Cannabis Companies - Seeking Alpha
- 26 days ago - Here Is A List Of 3 Canadian Marijuana Stocks To Watch 2025 - MarijuanaStocks